A practical way to reduce drug costs without compromising outcomes

IVPE stands for Interventional Pharmacoeconomics, a groundbreaking approach to reducing healthcare costs for health plans while improving patient outcomes. By conducting clinical trials that compare high-cost specialty drugs to lower-cost alternatives, IVPE helps health plans and employers save money and expand access to effective treatments.

01

Voluntary Enrollment

  • Patients are invited to participate in clinical programs designed to validate lower-cost treatment options.
  • Participation is fully voluntary
  • No changes unless the patient agrees

02

Self-Funded Model

  • As patients transition to optimized therapies, the savings generated during the program offset the cost of the clinical work.
  • No upfront cost for the health plan
  • Program funded through real-time savings

03

Long-Term Cost Reduction

  • Once validated, these approaches can be applied more broadly — delivering sustained savings without compromising outcomes.
  • Immediate savings during the program
  • Up to 90%+ cost reduction over time
How our clients win Mayo flyer

Rising drug costs burden privately and publicly-funded health insurers (particularly, self-insured employers in the United States). IVPE offers a data-driven solution that not only reduces costs but also promotes innovative, affordable healthcare options for patients in need.

Learn more about our IVPE Pipeline and how we’re transforming access to affordable therapies.